A COMPARATIVE STUDY OF EFFICACY OF ITRACONAZOLE VERSUS TERBINAFINE AND THEIR COST EFFECTIVENESS IN THE TREATMENT OF RESISTANT DERMATOPHYTOSIS OF SKIN AT NALANDA MEDICAL COLLEGE, A TERTIARY CARE TEACHING HOSPITAL OF PATNA.

Dr. Shubhra Bishwas, Dr. (Prof.) Sanjay Kumar

Abstract


Background-  Dermatophytoses are common fungal infections prevalent in hot and humid climate. Itraconazole and Terbinafine are commonly used antifungal agents for the treatment of dermatophytoses. However, increased resistance is being seen with conventional doses  of these drugs. Also, these infections are more common among low socio-economic population. Therefore, this study has been undertaken to compare the efficacy and cost effectiveness of Itraconazole and Terbinafine in increased dosages in resistant dermatophytoses of skin.

Objectives- To compare the efficacy of Itraconazole and Terbinafine in increased dosages in resistant dermatophytoses of skin and to select cheaper drug among them.

Materials and Methods- In this open, parallel, prospective, comparative study, 200 patients of Tinea cruris and Tinea corporis diagnosed clinically and confirmed by potassium hydroxide (KOH) test, were randomly and equally divided into two groups. Group I patients received  Itraconazole 200mg twice daily while group II patients received Terbinafine 250mg twice daily for 4 weeks. Patients were evaluated at the end of 2 and 4 weeks.At the end of 4 weeks KOH test was repeated to evaluate mycological cure.

Results- At the end of 4 weeks mycological and clinical cure was seen in 92% patients in group I while 75% patients in group II. Mild adverse effects like headache, taste disturbances and gastrointestinal upset were observed in few patients of both groups but none was significant enough to discontinue therapy. Cost of therapy was more with Itraconazole than that of Terbinafine.

Conclusion- High dose Itraconazole therapy is more effective than high dose Terbinafine therapy in resistant dermatophytoses. However cost of therapy is more in case of Itraconazole. But Terbinafine has higher failure rates and the duration of treatment may require longer, thereby reducing the cost difference. Therefore, Itraconazole seems superior to Terbinafine in the treatment of resistant T.corporis and T. cruris infection in higher doses.


Keywords


Itraconazole, Terbinafine, Resistant dermatophytosis

Full Text:

PDF

References


Naglot A, Shrimali DD, Nath BK, Gogoi HK, Veer V, et al. Recent trends of dermatophytosis in Northeast India and interpretation with published studies. Int J Curr Microbiol App Sci. 2015;4(11):111-20.

Harrison’s principles of internal medicine, 20th ed.p-1546.

Basic & clinical pharmacology, 14th ed.p-856-860.

Rajagopalan M, Inamadar A, Mittal A, et al. Expert Consensus on The Management of Dermatophytosis in India (ECTODERM India). BMC Dermatol. 2018;18(1):6. Published 2018 Jul 24. doi:10.1186/s12895-018-0073-1

Shakya NB, Jha MS. Dangol A, Shakya S, Shah A. Efficacy of itraconazole versus terbinafine for the treatment of tinea cruris. Med J Shree Birendra Hosp 2012;11:24-6.

Bhatia A, Kanish B, Badyal DK, Kate P, Choudhary S. Efficacy of oral terbinafine versus itraconazole in treatment of dermatophytic infection of skin – A prospective, randomized comparative study. Indian J Pharmacol 2019;51:116-9.

Bala Tripura Sundari Ankani/J Pharm. Sci. & Res. Vol. 7(8), 2015, 542-544.

Sigurgeirsson B, Olafsson JH, Steinsson JB, Paul C, Billstein S, Evans EG, et al. Long-term effectiveness of treatment with terbinafine vs. itraconazole in onychomycosis: A 5-year blinded prospective follow-up study. Arch Dermatol 2002;138:353-7.


Refbacks

  • There are currently no refbacks.